The Australian Centre for Disease Control: A New Era in Public Health, but Challenges Remain
Australia is about to embark on a new chapter in public health governance. The appointment of Professor Zoe Wainer as the inaugural Director-General of the Australian Centre for Disease Control (CDC) marks a significant shift in the country's approach to health threats. But as the CDC prepares to take center stage, it faces a myriad of challenges and expectations that will shape its journey ahead.
The CDC's mandate is clear: to bring together disease surveillance, expert analysis, and independent advice, with a focus on transparency. This comes after decades of advocacy from health leaders and organizations, particularly in light of the COVID-19 pandemic. The legislation passed in 2025, backed by substantial funding, sets the stage for a powerful new player in Australia's public health landscape.
But here's where it gets controversial. The CDC's initial priority areas include communicable disease surveillance, pandemic preparedness, environmental health, and occupational respiratory conditions. However, the exclusion of non-communicable diseases from its remit has sparked debate. The Lancet One Health Commission recommended a One Health approach to address shared risk factors for non-communicable diseases, but the CDC's mandate does not currently reflect this. This decision has left some questioning the agency's scope and authority.
The issue of Aboriginal and Torres Strait Islander leadership is another critical aspect. During the legislative process, concerns were raised about the bill's lack of recognition of structural drivers of Indigenous health. Senator Lidia Thorpe advocated for amendments to expand the definition of public health matters to include Indigenous health and determinants. While these amendments were not adopted, the Act provides for Indigenous representation on the agency's Advisory Council.
As the CDC takes shape, the focus shifts to execution. The question of how quickly it can build capability and meet expectations is paramount. The CDC inherits immediate pressures, including declining immunisation coverage, the threat of avian influenza, and occupational hazards. These challenges come at a time when public trust in institutions and evidence is waning.
The CDC's success will hinge on its ability to navigate these complexities. Its legislated transparency provisions will ensure its work is under public scrutiny. The agency's credibility will be built through rigorous processes, even as it faces heightened scrutiny in contentious areas. The CDC's relationship with governments, state systems, and communities will be pivotal in shaping its authority and impact.
The establishment of the CDC is a significant milestone, but it's just the beginning. The journey ahead will be an ongoing negotiation of evidence, trust, and accountability. As the CDC takes its first steps, the public health community watches with anticipation, eager to see how this new institution will shape Australia's response to health challenges.
